Medtronic PLC MDT

88.64 0.13 0.15% as of 25 Sep
Market cap
$112.2B
P/E
21.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Medtronic PLC (MDT) EV/EBITDA

As of 25 September 2026, Medtronic PLC (MDT) trades at a EV/EBITDA of 13.7×. Over the past ten years it has ranged from 12.0× (June 2026) to 32.7× (April 2021); the current reading is higher than 5% of that period. That is above the Medical Devices industry median of 11.8× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2026 13.0× (10.80%)
FY2025 14.6× (8.07%)
FY2024 15.9× (5.29%)
FY2023 16.7× (6.81%)
FY2022 18.0× (32.63%)
FY2021 26.7× 37.34%
FY2020 19.4× 28.36%
FY2019 15.1× 13.96%
FY2018 13.3× (18.51%)
FY2017 16.3× 2.62%

Quarterly

Period EV/EBITDA Change
Jul 2026 13.2× 1.72%
Apr 2026 13.0× (21.76%)
Jan 2026 16.6× 11.91%
Oct 2025 14.9× (1.10%)
43 more quarters

Against its own ten years

Low 12.0× High 32.7×
Ten-year median 16.1×
Current reading's percentile 5

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 8.6×
GEHC GE HealthCare Technologies Inc. compare 11.9×
STE STERIS plc compare 13.4×
MDT Medtronic PLC 13.7×
BSX Boston Scientific Corporation compare 13.8×
SYK Stryker Corporation compare 17.2×
ABT Abbott Laboratories compare 18.8×
DXCM DexCom, Inc. compare 23.2×
EW Edwards Lifesciences Corporation compare 28.6×
Medical Devices industry median 11.8×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MDT